Question 1

Does ProShare Advisors own VYGR stock?

Accepted Answer

No. ProShare Advisors exited its VYGR (Voyager Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 11,116 shares worth $43,685.

Question 2

How many shares of VYGR does ProShare Advisors own?

Accepted Answer

None since Q1 2026, when ProShare Advisors exited the position. Its Q4 2025 13F listed 11,116 shares worth $43,685.

Question 3

What is ProShare Advisors' VYGR position worth?

Accepted Answer

ProShare Advisors' VYGR position was worth $43,685 in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is ProShare Advisors buying or selling VYGR?

Accepted Answer

In Q1 2026, ProShare Advisors exited its entire VYGR position.

Question 5

When did ProShare Advisors first buy VYGR?

Accepted Answer

ProShare Advisors already held VYGR in its Q4 2018 13F, the earliest on record, and listed it in 13 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$3.86	0
2025-Q4	New	11,116	—	$43,685	0.0%	$3.93	28
2025-Q3	Exited	0	-100.0%	$0	0.0%	$4.67	0
2025-Q2	Decreased	11,618	-6.5%	$36,132	0.0%	$3.11	0
2025-Q1	Decreased	12,421	-20.1%	$41,983	0.0%	$3.38	0
2024-Q4	Decreased	15,543	-34.8%	$88,129	0.0%	$5.67	0
2024-Q3	New	23,854	—	$139,546	0.0%	$5.85	31